Entering text into the input field will update the search result below

FDA OKs Grifols Erytra Elfexis analyzer

Jan. 08, 2019 8:01 AM ETGrifols, S.A. (GRFS) StockBy: Douglas W. House, SA News Editor
  • The FDA approves Grifols (NASDAQ:GRFS)(OTCPK:GIKLY) Erytra Eflexis, an automated benchtop analyzer for pretransfusion compatibility testing. The company says the approval is the third in the U.S. for its blood typing portfolio.

Recommended For You

More Trending News

About GRFS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GRFS--
Grifols, S.A.